Your browser doesn't support javascript.
loading
Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale.
Liang, Zhenyu; Zhong, Nanshan; Chen, Rongchang; Ma, Qianli; Sun, Yongchang; Wen, Fuqiang; Tal-Singer, Ruth; Miller, Bruce E; Yates, Julie; Song, Jie; Compton, Chris; Ji, Beulah; Wu, Li; Yang, Yang; Jones, Paul; Zheng, Jinping.
Afiliação
  • Liang Z; State Key Laboratory of Respiratory Disease and National Clinical Research Center of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Zhong N; State Key Laboratory of Respiratory Disease and National Clinical Research Center of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Chen R; Pulmonary and Critical Care Dept, Shenzhen Institute of Respiratory Diseases, First Affiliated Hospital of South University of Science and Technology of China (Shenzhen People's Hospital), Shenzhen, Guangdong, China.
  • Ma Q; Chronic Respiratory Disease Care Centre, The North Kuanren General Hospital, Chongqing, China.
  • Sun Y; Dept of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
  • Wen F; Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, and Dept of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Tal-Singer R; GlaxoSmithKline, Collegeville, PA, USA.
  • Miller BE; No longer employees of GSK but were during the design of this study.
  • Yates J; GlaxoSmithKline, Collegeville, PA, USA.
  • Song J; No longer employees of GSK but were during the design of this study.
  • Compton C; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Ji B; No longer employees of GSK but were during the design of this study.
  • Wu L; GlaxoSmithKline, Research and Development, Shanghai, China.
  • Yang Y; GlaxoSmithKline, Brentford, UK.
  • Jones P; GlaxoSmithKline, Research and Development, Shanghai, China.
  • Zheng J; GlaxoSmithKline, Research and Development, Shanghai, China.
ERJ Open Res ; 7(3)2021 Jul.
Article em En | MEDLINE | ID: mdl-34527722

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: ERJ Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: ERJ Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido